Lenalidomide (Revlimid®), behandeling recidiverend en refractair multipel myeloom


1. Productinformatie lenalidomide (Revlimid®) via: http://www.emea.europa.eu, human medicines, EPAR’s.
2. CFH-rapport lenalidomide (Revlimid®), via www.cvz.nl, CFH-rapporten.
3. Weber DM, et al. Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America. N Engl J Med 2007; 357: 2133-2142.
4. Dimopoulos M, et al. Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma. N Engl J Med 2007; 357: 2123-2132. 

Auteurs

  • dr D. Bijl